Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.





PlumCare RWE partners with Lifebit on Greece's newborn genomic sequencing program, BeginNGS

APA-OTS-Meldungen aus dem Finanzsektor in der "BSN Extended Version"
Wichtige Originaltextaussendungen aus der Branche. Wir ergänzen vollautomatisch Bilder aus dem Fundus von photaq.com und Aktieninformationen aus dem Börse Social Network. Wer eine Korrektur zu den Beiträgen wünscht: mailto:office@boerse-social.com . Wir wiederum übernehmen keinerlei Haftung für Augenerkrankungen aufgrund von geballtem Grossbuchstabeneinsatz der Aussender. Wir meinen: Firmennamen, die länger als drei Buchstaben sind, schreibt man nicht durchgängig in Grossbuchstaben (Versalien).
Magazine aktuell


#gabb aktuell



25.01.2023, 4347 Zeichen

London (ots/PRNewswire) - Lifebit, a leading UK-based precision medicine software company, was awarded a three-year contract with PlumCare RWE to support the scaling of BeginNGS Greece, a pioneering newborn sequencing program.
* PlumCare RWE and Lifebit enter a three-year partnership to support Greece's pioneering national newborn genomic sequencing program, BeginNGS.
* Researchers will be able to access and analyse data securely in combination with global cohorts, whilst ensuring data is kept safe, private and in place in their secure environment using Lifebit's federated technology.
* This will help detect approximately 400 early onset but actionable genetic conditions in newborns, ensuring appropriate treatments can be given as early as possible, to help limit the impact of the diseases.
"We are thrilled to partner with Lifebit as it will allow us to securely connect data from Greece's first newborn screening program with global cohorts. With this, our researchers can gain crucial insights to better understand rare diseases and ultimately save lives," said Petros Tsipouras, Chief Executive Officer at PlumCare RWE.
Worldwide, thousands of children are born with rare genetic conditions that severely affect their quality of life. For approximately 400 early onset but actionable genetic conditions, these can be detected easily using genomic sequencing and appropriate interventions given, allowing affected families to lead lives unburdened by disease.
The BeginNGS program, backed by PlumCare RWE, the Rady Children's Institute for Genomic Medicine, and the National Organization of Public Health (EODY) in Greece, aims to sequence the genomes of 1,000 newborns by the end of 2023, scaling to all newborns in Greece by 2027. The program will use whole genome sequencing to diagnose many rare but actionable genetic conditions and identify treatment options before symptoms begin, a major advance over current practices that focus on children who are already critically ill.
Rare genetic conditions are, by definition, uncommon within the general population, therefore, to maximise and validate insights from the data, researchers critically need access to multiple large-scale cohorts of clinical-genomic data that are often in different places. Lifebit's powerful federated technology will advance these efforts, making this data interoperable and securely connected with global data cohorts.
Lifebit's Chief Executive Officer Dr Maria Chatzou Dunford commented, "We believe all biomedical data that can be used to save lives should be used. We are thrilled to support PlumCare to harness the power of securely connected clinico-genomic data. Our federated technology means that the data remains safe and private throughout by never leaving their secure environment and is used only by trusted researchers. By enabling secure data analysis, our technology will help to deliver life-saving breakthroughs in the diagnosis and treatment of rare diseases."
About Lifebit Biotech Ltd.
Lifebit builds enterprise data platforms for use by organisations with complex and sensitive biomedical datasets. Lifebit's patented federated technology securely unlocks access to biomedical data. From providing Trusted Research Environments for national precision medicine programmes to enabling pharmaceutical companies to discover new drug targets faster, Lifebit empowers customers to transform how they leverage sensitive biomedical data. Web: www.lifebit.ai/
About PlumCare RWE:
PlumCare RWE (Delaware, USA) is a Biotechnology and Healthcare data company. It combines real world evidence and multi-omics analysis to deliver actionable insights for individuals, companies and populations focusing on children. It is building a Global Pediatric Databank that can impact individual and population health and facilitate drug development and discovery. Its European headquarters is based in Athens, Greece. Web: https://www.plumcarerwe.com/
Photo - https://mma.prnewswire.com/media/1988317/Lifebit_PlumCare...
Photo - https://mma.prnewswire.com/media/1988326/Lifebit_PlumCare...
Logo - https://mma.prnewswire.com/media/1752754/lifebit_logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/plumcare-rwe-partn ers-with-lifebit-on-greeces-newborn-genomic-sequencing-program-beginn gs-301728323.html
Digital press kit: http://www.ots.at/pressemappe/PR156450/aom

BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Austrian Stocks in English: ATX TR reaches in Week 4 a new 11-Months-High, Erste Group wins 14th Stock Market Tournament




 

Aktien auf dem Radar:Flughafen Wien, S Immo, EVN, Kapsch TrafficCom, Agrana, CA Immo, ATX, ATX Prime, ATX TR, voestalpine, Wienerberger, Palfinger, Semperit, Mayr-Melnhof, Frequentis, Marinomed Biotech, Rosenbauer, RHI Magnesita, FACC, Frauenthal, Porr, Oberbank AG Stamm, BKS Bank Stamm, RBI, Strabag, Henkel, Qiagen, Münchener Rück, Fresenius Medical Care, Volkswagen Vz., Infineon.


Random Partner

AMAG Austria Metall AG
Die AMAG Austria Metall AG produziert Primäraluminium und Premium-Guss- und Walzprodukte. Im integrierten Werk in Ranshofen, Österreich werden die Kernkompetenzen im Recycling, Gießen, Walzen, Wärmebehandeln und Oberflächenveredeln kombiniert.

>> Besuchen Sie 64 weitere Partner auf boerse-social.com/partner


Mehr aktuelle OTS-Meldungen HIER

Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten


Ausgewählte Events von BSN-Partnern


Meistgelesen
>> mehr





PIR-Zeichnungsprodukte
AT0000A284P0
AT0000A2YAW0
AT0000A2X9C2


Newsflow
>> mehr

Börse Social Club Board
>> mehr
    BSN MA-Event Henkel
    BSN MA-Event Qiagen
    #gabb #1275

    Featured Partner Video

    Börsepeople im Podcast S4/09: Robert Karas

    Robert Karas, Kapitalmarktexperte seit mehr als drei Jahrzehnten und aktuell Chief Investment Officer und Partner der Bank Gutmann, ist der 1. Gast im neuen Jahr. Wir sprechen über frühe Jahre als ...

    Books josefchladek.com

    Jens Olof Lasthein
    Far — Near
    2022
    Diep Publishing

    Katrien de Blauwer
    You Could At Least Pretend to Like Yellow
    2020
    Libraryman

    Lee Baldwin
    Lee Baldwin
    2023
    Hunters Point Press

    Damian Michał Heinisch
    Erde, Feuer, Wind, Wasser
    2021
    Kehrer Verlag

    Joze Suhadolnik
    Cirkus
    2022
    Rostfreipublishing

    PlumCare RWE partners with Lifebit on Greece's newborn genomic sequencing program, BeginNGS


    25.01.2023, 4347 Zeichen

    London (ots/PRNewswire) - Lifebit, a leading UK-based precision medicine software company, was awarded a three-year contract with PlumCare RWE to support the scaling of BeginNGS Greece, a pioneering newborn sequencing program.
    * PlumCare RWE and Lifebit enter a three-year partnership to support Greece's pioneering national newborn genomic sequencing program, BeginNGS.
    * Researchers will be able to access and analyse data securely in combination with global cohorts, whilst ensuring data is kept safe, private and in place in their secure environment using Lifebit's federated technology.
    * This will help detect approximately 400 early onset but actionable genetic conditions in newborns, ensuring appropriate treatments can be given as early as possible, to help limit the impact of the diseases.
    "We are thrilled to partner with Lifebit as it will allow us to securely connect data from Greece's first newborn screening program with global cohorts. With this, our researchers can gain crucial insights to better understand rare diseases and ultimately save lives," said Petros Tsipouras, Chief Executive Officer at PlumCare RWE.
    Worldwide, thousands of children are born with rare genetic conditions that severely affect their quality of life. For approximately 400 early onset but actionable genetic conditions, these can be detected easily using genomic sequencing and appropriate interventions given, allowing affected families to lead lives unburdened by disease.
    The BeginNGS program, backed by PlumCare RWE, the Rady Children's Institute for Genomic Medicine, and the National Organization of Public Health (EODY) in Greece, aims to sequence the genomes of 1,000 newborns by the end of 2023, scaling to all newborns in Greece by 2027. The program will use whole genome sequencing to diagnose many rare but actionable genetic conditions and identify treatment options before symptoms begin, a major advance over current practices that focus on children who are already critically ill.
    Rare genetic conditions are, by definition, uncommon within the general population, therefore, to maximise and validate insights from the data, researchers critically need access to multiple large-scale cohorts of clinical-genomic data that are often in different places. Lifebit's powerful federated technology will advance these efforts, making this data interoperable and securely connected with global data cohorts.
    Lifebit's Chief Executive Officer Dr Maria Chatzou Dunford commented, "We believe all biomedical data that can be used to save lives should be used. We are thrilled to support PlumCare to harness the power of securely connected clinico-genomic data. Our federated technology means that the data remains safe and private throughout by never leaving their secure environment and is used only by trusted researchers. By enabling secure data analysis, our technology will help to deliver life-saving breakthroughs in the diagnosis and treatment of rare diseases."
    About Lifebit Biotech Ltd.
    Lifebit builds enterprise data platforms for use by organisations with complex and sensitive biomedical datasets. Lifebit's patented federated technology securely unlocks access to biomedical data. From providing Trusted Research Environments for national precision medicine programmes to enabling pharmaceutical companies to discover new drug targets faster, Lifebit empowers customers to transform how they leverage sensitive biomedical data. Web: www.lifebit.ai/
    About PlumCare RWE:
    PlumCare RWE (Delaware, USA) is a Biotechnology and Healthcare data company. It combines real world evidence and multi-omics analysis to deliver actionable insights for individuals, companies and populations focusing on children. It is building a Global Pediatric Databank that can impact individual and population health and facilitate drug development and discovery. Its European headquarters is based in Athens, Greece. Web: https://www.plumcarerwe.com/
    Photo - https://mma.prnewswire.com/media/1988317/Lifebit_PlumCare...
    Photo - https://mma.prnewswire.com/media/1988326/Lifebit_PlumCare...
    Logo - https://mma.prnewswire.com/media/1752754/lifebit_logo.jpg
    View original content:https://www.prnewswire.co.uk/news-releases/plumcare-rwe-partn ers-with-lifebit-on-greeces-newborn-genomic-sequencing-program-beginn gs-301728323.html
    Digital press kit: http://www.ots.at/pressemappe/PR156450/aom

    BSN Podcasts
    Christian Drastil: Wiener Börse Plausch

    Austrian Stocks in English: ATX TR reaches in Week 4 a new 11-Months-High, Erste Group wins 14th Stock Market Tournament




     

    Aktien auf dem Radar:Flughafen Wien, S Immo, EVN, Kapsch TrafficCom, Agrana, CA Immo, ATX, ATX Prime, ATX TR, voestalpine, Wienerberger, Palfinger, Semperit, Mayr-Melnhof, Frequentis, Marinomed Biotech, Rosenbauer, RHI Magnesita, FACC, Frauenthal, Porr, Oberbank AG Stamm, BKS Bank Stamm, RBI, Strabag, Henkel, Qiagen, Münchener Rück, Fresenius Medical Care, Volkswagen Vz., Infineon.


    Random Partner

    AMAG Austria Metall AG
    Die AMAG Austria Metall AG produziert Primäraluminium und Premium-Guss- und Walzprodukte. Im integrierten Werk in Ranshofen, Österreich werden die Kernkompetenzen im Recycling, Gießen, Walzen, Wärmebehandeln und Oberflächenveredeln kombiniert.

    >> Besuchen Sie 64 weitere Partner auf boerse-social.com/partner


    Mehr aktuelle OTS-Meldungen HIER

    Useletter

    Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

    Newsletter abonnieren

    Runplugged

    Infos über neue Financial Literacy Audio Files für die Runplugged App
    (kostenfrei downloaden über http://runplugged.com/spreadit)

    per Newsletter erhalten


    Ausgewählte Events von BSN-Partnern


    Meistgelesen
    >> mehr





    PIR-Zeichnungsprodukte
    AT0000A284P0
    AT0000A2YAW0
    AT0000A2X9C2


    Newsflow
    >> mehr

    Börse Social Club Board
    >> mehr
      BSN MA-Event Henkel
      BSN MA-Event Qiagen
      #gabb #1275

      Featured Partner Video

      Börsepeople im Podcast S4/09: Robert Karas

      Robert Karas, Kapitalmarktexperte seit mehr als drei Jahrzehnten und aktuell Chief Investment Officer und Partner der Bank Gutmann, ist der 1. Gast im neuen Jahr. Wir sprechen über frühe Jahre als ...

      Books josefchladek.com

      Lee Baldwin
      Lee Baldwin
      2023
      Hunters Point Press

      Harri Pälviranta
      Wall Tourist
      2022
      Kult Books

      Will Anderson
      Death In A Good District
      2015
      Yewtree Press

      Yves Glorion
      soixante-dix-sept / dix-neuf (77/19)
      2020
      Self published

      Lars Borges & Luzie Kurth
      We Share the Meal
      2022
      Kehrer Verlag